- Home
- PRTA vs EFR Comparison
PRTA vs EFR Comparison
Compare PRTA & EFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- EFR
- Stock Information
- Founded
- PRTA 2012
- EFR 2003
- Country
- PRTA Ireland
- EFR United States
- Employees
- PRTA N/A
- EFR N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- EFR Trusts Except Educational Religious and Charitable
- Sector
- PRTA Health Care
- EFR Finance
- Exchange
- PRTA Nasdaq
- EFR Nasdaq
- Market Cap
- PRTA 472.1M
- EFR 344.0M
- IPO Year
- PRTA N/A
- EFR N/A
- Fundamental
- Price
- PRTA $8.20
- EFR $11.71
- Analyst Decision
- PRTA Buy
- EFR
- Analyst Count
- PRTA 10
- EFR 0
- Target Price
- PRTA $14.86
- EFR N/A
- AVG Volume (30 Days)
- PRTA 1.2M
- EFR 88.6K
- Earning Date
- PRTA 08-04-2025
- EFR 01-01-0001
- Dividend Yield
- PRTA N/A
- EFR 9.43%
- EPS Growth
- PRTA N/A
- EFR N/A
- EPS
- PRTA N/A
- EFR 1.69
- Revenue
- PRTA $10,341,000.00
- EFR N/A
- Revenue This Year
- PRTA N/A
- EFR N/A
- Revenue Next Year
- PRTA $389.77
- EFR N/A
- P/E Ratio
- PRTA N/A
- EFR $7.74
- Revenue Growth
- PRTA N/A
- EFR N/A
- 52 Week Low
- PRTA $4.32
- EFR $10.95
- 52 Week High
- PRTA $22.83
- EFR $13.29
- Technical
- Relative Strength Index (RSI)
- PRTA 58.73
- EFR 43.60
- Support Level
- PRTA $8.05
- EFR $11.64
- Resistance Level
- PRTA $8.73
- EFR $11.79
- Average True Range (ATR)
- PRTA 0.38
- EFR 0.09
- MACD
- PRTA -0.05
- EFR 0.01
- Stochastic Oscillator
- PRTA 47.62
- EFR 60.00
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About EFR Eaton Vance Senior Floating-Rate Fund of Beneficial Interest
Eaton Vance Senior Floating Rate Trust is a diversified, closed-end management investment company. Its primary investment objective is to provide a high level of current income. As a secondary objective, the fund intends to seek capital preservation. Its portfolio of investments consists of Software, Health Care Providers & Services, Machinery, Chemicals, Professional Services, IT Services, Hotels, Restaurants & Leisure, Capital Markets, Specialty Retail, Commercial Services & Supplies, and other areas. The trust invests in below investment grade floating rate loans, which are considered speculative because of the credit risk of their issuers.